VRNA - Verona Pharma plc
106.91
0.120 0.112%
Share volume: 1,871,959
Last Updated: 10-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$106.79
0.12
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 02-27-2025 | 04-29-2025 | 08-06-2025 | |
| Assets | ||||
| Total Assets | 474.242 M | 525.936 M | 572.871 M | |
| Current Assets | 453.572 M | 501.025 M | 548.851 M | |
| Inventories | 6.249 M | 7.244 M | 8.612 M | |
| Other Current Assets | 2.735 M | 12.955 M | 3.872 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 399.757 M | 401.415 M | 438.016 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.105 M | 1.048 M | 991.000 K | |
| Other Assets | 19.565 M | 23.863 M | 23.029 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 474.242 M | 525.936 M | 572.871 M | |
| Total liabilities | 269.683 M | 299.341 M | 294.598 M | |
| Total current liabilities | 42.681 M | 56.544 M | 51.238 M | |
| Accounts Payable | 11.266 M | 9.077 M | 3.434 M | |
| Other liabilities | 106.661 M | 1.055 M | 926.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 120.341 M | 241.742 M | 242.434 M | |
| Other liabilities | 106.661 M | 1.055 M | 926.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 204.559 M | 226.595 M | 278.273 M | |
| Common stock | 773.220 M | 811.390 M | 850.939 M | |
| Retained earnings | -562.401 M | -578.792 M | -567.101 M |